Evidence map›Paper›PMID 41324335›Full record

ArticleThe Journal of infectious diseases2026

High Seropositivity to rK39 and Capture of Leishmania-Infected Sand Flies in Bihar and Jharkhand Emphasize the Need for Post-Elimination Surveillance of Visceral Leishmaniasis in India.

Eva Iniguez, Khushbu Priyamvada, Pushkar Dubey, Joy Bindroo, Mohammad Shahnawaz, Asahar Alam, Shalini Singh, Avneesh Kumar, Gaurav Kumar, Pankaj Kumar and 18 more

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Eva IniguezVector Molecular Biology Section, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville, Maryland, USA.ORCID 0009-0006-9027-0523
Khushbu PriyamvadaBihar Technical Support Program, Patna, Bihar, India.
Pushkar DubeyBihar Technical Support Program, Patna, Bihar, India.ORCID 0000-0002-4949-326X
Joy BindrooBihar Technical Support Program, Patna, Bihar, India.ORCID 0000-0002-2242-220X
Mohammad ShahnawazBihar Technical Support Program, Patna, Bihar, India.
Asahar AlamBihar Technical Support Program, Patna, Bihar, India.
Shalini SinghBihar Technical Support Program, Patna, Bihar, India.
Avneesh KumarBihar Technical Support Program, Patna, Bihar, India.
Gaurav KumarBihar Technical Support Program, Patna, Bihar, India.
Pankaj KumarBihar Technical Support Program, Patna, Bihar, India.
Shani PandeyBihar Technical Support Program, Patna, Bihar, India.
Patrick HuffcuttVector Molecular Biology Section, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville, Maryland, USA.ORCID 0000-0002-7215-1284
Claudio MenesesVector Molecular Biology Section, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville, Maryland, USA.
Debanjan PatraBihar Technical Support Program, Patna, Bihar, India.
Indranil SuklaBihar Technical Support Program, Patna, Bihar, India.
Asgar AliBihar Technical Support Program, Patna, Bihar, India.ORCID 0000-0003-2153-5066
Prabhas Kumar MishraBihar Technical Support Program, Patna, Bihar, India.
Bikas SinhaBihar Technical Support Program, Patna, Bihar, India.
Tanmay MahapatraBihar Technical Support Program, Patna, Bihar, India.
Tiago Donatelli SerafimVector Molecular Biology Section, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville, Maryland, USA.
Ashok KumarVector Borne Disease Control Program, Government of Bihar, Patna, Bihar, India.
Birendra Kumar SinghVector Borne Disease Control Program, Government of Jharkhand, Ranchi, Jharkhand, India.
Jesus G ValenzuelaVector Molecular Biology Section, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville, Maryland, USA.
Allen HightowerIndependent Consultant, Atlanta Georgia, USA.
Sridhar SrikantiahBihar Technical Support Program, Patna, Bihar, India.
Sadhana SharmaDepartment of Biochemistry, All India Institute of Medical Sciences, Patna, Bihar, India.ORCID 0000-0002-2400-0051
Caryn BernDepartment of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0001-8195-7303
Shaden KamhawiVector Molecular Biology Section, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville, Maryland, USA.

Funding

Bill and Melinda Gates Foundation OPP1196454Gates Foundation INV-008856Intramural Research ProgramNIH HHSUnited States GovernmentU.S. Department of Health and Human Services
6 · The paper itself

Abstract

backgroundIndia is transitioning to the visceral leishmaniasis (VL) post-elimination phase where robust surveillance is critical to sustaining elimination. We conducted a targeted longitudinal study combining epidemiological, serological, and entomological data in endemic villages in Bihar and Jharkhand states to assess active VL transmission levels.

methodsOur investigation was conducted in the villages of Rahar Diyara, Bihar, and Murbhanga, Jharkhand, based on spatial distribution of recently reported VL cases. Samples were collected quarterly from December 2021 to September 2022 in Rahar Diyara, and April 2022 to May 2023 in Murbhanga, to determine seroprevalence against Leishmania rK39 antigen. Sand flies were collected bi-weekly in Rahar Diyara (February to December, 2022) and Murbhanga (April to December, 2022) from different microhabitats and analyzed by qPCR targeting Leishmania kDNA.

resultsrK39 Leishmania seroprevalence ranged from 20% to 30% in both villages. Murbhanga, an outbreak village, exhibited higher antibody levels in 9-23% of subjects compared with the low incidence village, Rahar Diyara (3-6%), reflecting a higher intensity of transmission in Murbhanga. Despite implementation of indoor residual spraying, Leishmania-infected sand flies were found in both villages, with 1.4% (4/285) and 1.2% (5/431) positive pools in Rahar Diyara and Murbhanga, respectively. Infected sand fly pools were collected from diverse microhabitats, predominantly from vegetation in Rahar Diyara and cattle enclosures in Murbhanga, indicative of focal and distinct patterns of transmission.

conclusionsLow-level Leishmania transmission persists in India highlighting criticality of continued surveillance. Combining epidemiological, serological, and entomological surveys improves rapid outbreak assessment and intervention, and enhances efficacy of surveillance to sustain VL elimination.

Indexed as

Antigens, ProtozoanLeishmaniaLeishmaniasis, VisceralProtozoan ProteinsPsychodidaeAdolescentAdultAnimalsAntibodies, ProtozoanFemaleHumansIndiaInsect VectorsLongitudinal StudiesMaleMiddle AgedAntibodies, ProtozoanAntigens, ProtozoanProtozoan ProteinsIndiainfected sand fliesrK39 antigensurveillancevisceral leishmaniasis

Identifiers

PMID41324335
PMCPMC13017422

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.